18 AI News and Ratings Making Waves on Wall Street

Page 14 of 16

3. Amgen Inc. (NASDAQ:AMGN)

Number of Hedge Fund Holders: 72

Amgen Inc. (NASDAQ:AMGN) develops and manufactures biopharmaceuticals for conditions like arthritis, osteoporosis, cancer, and cardiovascular diseases, distributing through healthcare providers and partnerships.

On February 24, Reuters reported that Amgen is investing $200 million in a new technology center in Hyderabad, India, with plans for further investments. The facility is focused on AI and data science for drug development and aims to employ around 2,000 people by the end of 2025, with 300 already onboard.

The announcement comes ahead of the BioAsia conference, where executives from major pharmaceutical companies, including Amgen, Eli Lilly, and Novartis, will participate. Amgen’s expansion aligns with broader U.S.-India efforts to strengthen collaboration in emerging technologies. Meanwhile, potential U.S. tariffs on pharmaceutical imports could impact Indian drugmakers, given their significant reliance on the American market, the report stated.

Page 14 of 16